New Genetic Study Links Common Amino Acid Tyrosine to Reduced Lifespan Exclusively in Men

A comprehensive, large-scale epidemiological and genetic investigation involving more than 270,000 participants has illuminated a potential biological contributor to human aging, pointing to a common dietary amino acid as a factor in male longevity. Published in the peer-reviewed journal Aging-US under the title "The role of phenylalanine and tyrosine in longevity: a cohort and Mendelian randomization study," the research was spearheaded by an international team of scientists from the University of Hong Kong and the University of Georgia, including Jie V. Zhao, Yitang Sun, Junmeng Zhang, and Kaixiong Ye.

The findings indicate a stark physiological divergence between the sexes. According to the data, elevated levels of tyrosine—a fundamental amino acid integral to human metabolism, protein synthesis, and central nervous system function—are strongly associated with a shortened life expectancy in men. Conversely, the study detected no statistically significant correlation between tyrosine concentrations and longevity in women. While the research offers a compelling piece of the puzzle regarding why men and women experience aging differently, the scientific community emphasizes that these findings represent an initial step and cannot yet be translated into direct clinical recommendations or dietary mandates.

Main Facts and the Biological Role of Tyrosine

Amino acids serve as the foundational molecular building blocks utilized by the human body to synthesize proteins, maintain tissue integrity, and regulate biochemical pathways. Among these, phenylalanine and tyrosine occupy critical roles. Tyrosine is classified as a non-essential amino acid, meaning the body can manufacture it from phenylalanine, though it is also abundantly consumed through dietary protein sources such as meat, dairy, fish, nuts, and beans, as well as through popular commercial dietary supplements.

Beyond its structural role in proteins, tyrosine acts as a vital metabolic precursor. The human body converts tyrosine into several key neurotransmitters and hormones, most notably dopamine, norepinephrine, and epinephrine. These chemical messengers facilitate communication between nerve cells, orchestrating a wide spectrum of physiological and psychological processes ranging from motor control and stress adaptation to cognitive focus, mood regulation, and motivation.

Despite the acknowledged importance of tyrosine in day-to-day metabolic function, the long-term systemic consequences of chronically elevated blood concentrations of these amino acids on human aging have remained poorly understood. This knowledge gap motivated the research team to examine whether natural variations in amino acid levels could predict or influence human lifespan.

Chronology and Methodology of the UK Biobank Cohort Study

To explore the hypothesis, the researchers turned to the UK Biobank, a globally recognized, population-based biomedical database containing extensive health, lifestyle, and genetic profiles from more than half a million volunteers across the United Kingdom. Initiated in the early 2000s, the UK Biobank has become a cornerstone of modern genetic and epidemiological research, allowing scientists to track long-term health outcomes against baseline biological markers.

For this study, the research team analyzed data drawn from a cohort exceeding 270,000 participants. The investigation utilized a dual methodological framework to ensure robust conclusions. First, the team conducted a traditional observational analysis, examining blood plasma concentrations of phenylalanine and tyrosine against mortality records and predicted lifespan outcomes.

To move beyond mere correlation and investigate potential cause-and-effect relationships, the researchers applied Mendelian randomization—an advanced epidemiological technique that uses measured genetic variants as instrumental proxies for specific environmental or biochemical exposures. Because an individual’s genetic code is established at conception, long before the onset of lifestyle choices, environmental exposures, or clinical disease, Mendelian randomization helps minimize the confounding variables and reverse causation that often complicate standard observational studies.

Supporting Data and Empirical Findings

Initial observational models suggested that elevated concentrations of both phenylalanine and tyrosine were correlated with an increased risk of mortality. However, when the investigators deployed multivariable models and genetic Mendelian randomization to isolate independent effects, phenylalanine’s association disappeared after controlling for tyrosine. Phenylalanine showed no independent association with lifespan in either men or women once tyrosine levels were accounted for.

Tyrosine, however, consistently stood out. The genetic analyses pointed to a potentially causal relationship between elevated systemic tyrosine and reduced life expectancy specifically within the male cohort. According to the researchers’ statistical modeling, higher genetically predicted tyrosine levels could correspond to a reduction in male lifespan of nearly one full year.

Crucially, this pattern was entirely absent in the female cohort. The study revealed no significant effect of tyrosine concentrations on female longevity. Furthermore, the data indicated that men naturally tend to exhibit higher baseline serum concentrations of tyrosine compared to women. While the researchers caution that this disparity does not definitively prove tyrosine is the primary driver of the broader, well-documented gender gap in average human lifespan, it highlights a previously unappreciated metabolic divergence between the sexes.

Broader Impact, Potential Mechanisms, and Implications

The identification of a sex-specific longevity marker opens new avenues for biogerontology, the scientific study of the biological processes of aging. Scientists are now working to determine the exact biochemical pathways through which excess tyrosine might exert a detrimental effect on male physiology over decades.

While definitive mechanisms remain under investigation, researchers have proposed several plausible hypotheses. One leading theory involves insulin resistance—a pathological condition wherein peripheral cells fail to respond effectively to insulin, the primary hormone regulating blood glucose homeostasis. Insulin resistance is tightly linked to age-related morbidities, including type 2 diabetes, cardiovascular disease, and metabolic syndrome. Alterations in amino acid metabolism are frequently observed in insulin-resistant states, suggesting a possible mechanistic bridge between high tyrosine and accelerated aging processes in men.

Another hypothesis centers on neuroendocrine stress response systems. Tyrosine serves as the gateway for catecholamine synthesis, governing the body’s acute and chronic responses to stress. Because the hypothalamic-pituitary-adrenal (HPA) axis and related neuroendocrine pathways operate under distinct regulatory controls in males and females due to hormonal dimorphism, the physiological toll of chronic high-level tyrosine signaling may manifest differently across the sexes.

Implications for Dietary Supplements and Future Research

The findings arrive at a time when tyrosine supplements are widely marketed and consumed by the general public, often touted for their purported ability to enhance cognitive performance, sharpen alertness, combat mental fatigue, and improve athletic focus. The new data inevitably raise safety questions regarding whether the long-term maintenance of chronically elevated tyrosine levels could carry unforeseen physiological costs.

Nevertheless, experts urge caution in interpreting the public health implications of the study. The researchers did not directly evaluate commercial tyrosine supplements, nor did they conduct a clinical trial where individuals ingested supplemental tyrosine over long periods. Consequently, the study does not demonstrate that taking a standard tyrosine supplement will directly shorten an individual’s life.

Instead, the investigation evaluated endogenous blood concentrations of tyrosine and their statistical association with longevity. The authors suggest that individuals who naturally present with unusually high serum tyrosine levels might theoretically benefit from targeted dietary modifications aimed at reducing systemic exposure. Such interventions could potentially involve moderating total dietary protein intake. However, whether actively lowering blood tyrosine concentrations through diet or lifestyle modifications can safely extend human lifespan or improve healthspan remains entirely unproven.

As the scientific community digests these findings, the authors emphasize that extensive further research is required. Future studies must replicate these genetic associations in diverse international cohorts, definitively uncover the molecular mechanisms driving the observed sex differences, and determine whether interventions in amino acid metabolism can be safely harnessed to promote healthier aging in humans.